Super Investor #36 in our series is Guy Spier – The Thoughtful Disciple of Buffett. Known for his reflective investing mindset and his deep value orientation, Guy Spier has carved out a unique place in the world of long-term investing. While he may not manage billions like some of his peers,…
Tag: NSRGY
How Much Diversification Does Your Portfolio Need?
Why Diversification Matters for Long-Term Investors Diversification for buy-and-hold investors is a cornerstone of risk management. Whether you’re just starting out or have built a substantial portfolio, understanding how much diversification is enough—and not too much—is essential to growing and protecting your wealth over the long run. At its core,…
Super Investor #32: Thomas Russo – The Global Value Investor
Super Investor #32 in our series is Thomas Russo, a master of global value investing, known for his focus on companies with strong brands and the ability to reinvest profits at high rates. Russo’s approach emphasizes long-term ownership of businesses that generate sustainable cash flow and reinvest in their growth,…
Food and Beverage Stocks: Consistent Performers in Any Economy
Are Food and Beverage Stocks Consistent Performers in Any Economy? In uncertain economic climates, finding reliable and resilient stocks can be a challenge. Food and beverage companies, however, often provide a steady presence in a portfolio because of their essential role in meeting basic human needs. The demand for their…
Super Investor Series: John Templeton – The Father of Global Investing
Super Investor #5 in our series is John Templeton – The Father of Global Investing. Who Was John Templeton? John Templeton was one of the most respected and successful investors of the 20th century. Known for his pioneering approach to global investing and his disciplined value-investing philosophy, Templeton built a fortune…
How Weight-loss Treatments Could Disrupt Other Industries: The Impact of GLP-1 Drugs
The medical landscape is undergoing a seismic shift with the rise of GLP-1 (glucagon-like peptide-1) diabetes and weight-loss treatments. Novo Nordisk’s Ozempic and Wegovy, along with Eli Lilly’s Mounjaro, have been at the forefront of this revolution. These treatments, originally developed for managing type-2 diabetes, have shown remarkable efficacy in…